Chemistry:Altinicline
From HandWiki
Short description: Chemical compound
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C12H14N2 |
Molar mass | 186.252 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Altinicline (SIB-1508Y, SIB-1765F) is a drug which acts as an agonist at neural nicotinic acetylcholine receptors with high selectivity for the α4β2 subtype.[1][2] It stimulates release of dopamine and acetylcholine in the brain in both rodent and primate models,[3] and progressed as far as Phase II clinical trials for Parkinson's disease,[4] where "no antiparkinsonian or cognitive-enhancing effects were demonstrated", although its current status is unclear.
References
- ↑ "Recombinant human receptors and functional assays in the discovery of altinicline (SIB-1508Y), a novel acetylcholine-gated ion channel (nAChR) agonist". Pharmaceutica Acta Helvetiae 74 (2–3): 125–30. March 2000. doi:10.1016/S0031-6865(99)00024-2. PMID 10812948.
- ↑ "Expedient five-step synthesis of SIB-1508Y from natural nicotine". The Journal of Organic Chemistry 71 (22): 8673–5. October 2006. doi:10.1021/jo0616052. PMID 17064057.
- ↑ "Pharmacological characterization of (S)-(2)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine HCl (SIB-1508Y, Altinicline), a novel nicotinic acetylcholine receptor agonist". Brain Research 1234: 16–24. October 2008. doi:10.1016/j.brainres.2008.07.063. PMID 18692487.
- ↑ The Parkinson Study Group (February 2006). "Randomized placebo-controlled study of the nicotinic agonist SIB-1508Y in Parkinson disease". Neurology 66 (3): 408–10. doi:10.1212/01.wnl.0000196466.99381.5c. PMID 16476941.
![]() | Original source: https://en.wikipedia.org/wiki/Altinicline.
Read more |